Allogene Therapeutics | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.